ETAPA I Peptide-based Tumor Associated Antigen Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ETAPA I Peptide-based Tumor Associated Antigen Vaccine, covering 2025-10-31 to 2025-10-31. Get the full timeline:
Most recent: Clinical Trial Update: ETAPA I: Peptide-based Tumor Associated Antigen Vaccine in GBM [Phase 1]